Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

423 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.
Hardin M, Cho MH, McDonald ML, Wan E, Lomas DA, Coxson HO, MacNee W, Vestbo J, Yates JC, Agusti A, Calverley PM, Celli B, Crim C, Rennard S, Wouters E, Bakke P, Bhatt SP, Kim V, Ramsdell J, Regan EA, Make BJ, Hokanson JE, Crapo JD, Beaty TH, Hersh CP; ECLIPSE and COPDGene Investigators; COPDGene Investigators—clinical centers. Hardin M, et al. Among authors: macnee w. Pharmacogenomics J. 2016 Aug;16(4):326-35. doi: 10.1038/tpj.2015.65. Epub 2015 Oct 27. Pharmacogenomics J. 2016. PMID: 26503814 Free PMC article.
Validity of physical activity monitors during daily life in patients with COPD.
Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S, Burtin C, Regueiro EM, Vogiatzis I, Hopkinson NS, Polkey MI, Wilson FJ, Macnee W, Westerterp KR, Troosters T; PROactive Consortium. Rabinovich RA, et al. Among authors: macnee w. Eur Respir J. 2013 Nov;42(5):1205-15. doi: 10.1183/09031936.00134312. Epub 2013 Feb 8. Eur Respir J. 2013. PMID: 23397303 Free article. Clinical Trial.
Oxidants and COPD.
MacNee W. MacNee W. Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):627-41. doi: 10.2174/156801005774912815. Curr Drug Targets Inflamm Allergy. 2005. PMID: 17305519 Review.
423 results